193 related articles for article (PubMed ID: 25360158)
1. Functional consequences of somatic mutations in cancer using protein pocket-based prioritization approach.
Vuong H; Cheng F; Lin CC; Zhao Z
Genome Med; 2014; 6(10):81. PubMed ID: 25360158
[TBL] [Abstract][Full Text] [Related]
2. Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach.
Zhao J; Cheng F; Wang Y; Arteaga CL; Zhao Z
Mol Cell Proteomics; 2016 Feb; 15(2):642-56. PubMed ID: 26657081
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.
Zhao J; Cheng F; Zhao Z
Cancer Res; 2017 Jun; 77(11):2810-2821. PubMed ID: 28364002
[TBL] [Abstract][Full Text] [Related]
4. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
[TBL] [Abstract][Full Text] [Related]
5. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development.
Chen L; Miao Y; Liu M; Zeng Y; Gao Z; Peng D; Hu B; Li X; Zheng Y; Xue Y; Zuo Z; Xie Y; Ren J
Front Genet; 2018; 9():254. PubMed ID: 30065750
[TBL] [Abstract][Full Text] [Related]
7. A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types.
Cheng F; Liu C; Lin CC; Zhao J; Jia P; Li WH; Zhao Z
PLoS Comput Biol; 2015 Sep; 11(9):e1004497. PubMed ID: 26352260
[TBL] [Abstract][Full Text] [Related]
8. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential synthetic lethal genes to p53 using a computational biology approach.
Wang X; Simon R
BMC Med Genomics; 2013 Sep; 6():30. PubMed ID: 24025726
[TBL] [Abstract][Full Text] [Related]
10. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
11. Domain landscapes of somatic mutations in cancer.
Nehrt NL; Peterson TA; Park D; Kann MG
BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
[TBL] [Abstract][Full Text] [Related]
12. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.
Cheng F; Jia P; Wang Q; Lin CC; Li WH; Zhao Z
Mol Biol Evol; 2014 Aug; 31(8):2156-69. PubMed ID: 24881052
[TBL] [Abstract][Full Text] [Related]
13. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
14. Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census.
Malhotra S; Alsulami AF; Heiyun Y; Ochoa BM; Jubb H; Forbes S; Blundell TL
PLoS One; 2019; 14(7):e0219935. PubMed ID: 31323058
[TBL] [Abstract][Full Text] [Related]
15. Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Kim D; Li R; Dudek SM; Wallace JR; Ritchie MD
Pac Symp Biocomput; 2015; ():96-107. PubMed ID: 25592572
[TBL] [Abstract][Full Text] [Related]
16. Cancer3D: understanding cancer mutations through protein structures.
Porta-Pardo E; Hrabe T; Godzik A
Nucleic Acids Res; 2015 Jan; 43(Database issue):D968-73. PubMed ID: 25392415
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
18. Impacts of somatic mutations on gene expression: an association perspective.
Jia P; Zhao Z
Brief Bioinform; 2017 May; 18(3):413-425. PubMed ID: 27127206
[TBL] [Abstract][Full Text] [Related]
19. Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.
Liu C; Zhao J; Lu W; Dai Y; Hockings J; Zhou Y; Nussinov R; Eng C; Cheng F
PLoS Comput Biol; 2020 Feb; 16(2):e1007701. PubMed ID: 32101536
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development.
Mészáros B; Zeke A; Reményi A; Simon I; Dosztányi Z
Biol Direct; 2016 May; 11():23. PubMed ID: 27150584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
